BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2903614)

  • 1. Ontogeny of the dopamine and cyclic adenosine-3':5'-monophosphate-regulated phosphoprotein (DARPP-32) in the pre- and postnatal mouse central nervous system.
    Foster GA; Schultzberg M; Kökfelt T; Goldstein M; Hemmings HC; Ouimet CC; Walaas SI; Greengard P
    Int J Dev Neurosci; 1988; 6(4):367-86. PubMed ID: 2903614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a dopamine- and cyclic adenosine 3':5'-monophosphate-regulated phosphoprotein (DARPP-32) in the prenatal rat central nervous system, and its relationship to the arrival of presumptive dopaminergic innervation.
    Foster GA; Schultzberg M; Hökfelt T; Goldstein M; Hemmings HC; Ouimet CC; Walaas SI; Greengard P
    J Neurosci; 1987 Jul; 7(7):1994-2018. PubMed ID: 2886563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization.
    Ouimet CC; Miller PE; Hemmings HC; Walaas SI; Greengard P
    J Neurosci; 1984 Jan; 4(1):111-24. PubMed ID: 6319625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DARPP-32, a dopamine- and cyclic AMP-regulated phosphoprotein in tanycytes of the mediobasal hypothalamus: distribution and relation to dopamine and luteinizing hormone-releasing hormone neurons and other glial elements.
    Meister B; Hökfelt T; Tsuruo Y; Hemmings H; Ouimet C; Greengard P; Goldstein M
    Neuroscience; 1988 Nov; 27(2):607-22. PubMed ID: 2905789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemical localization of DARPP-32, a dopamine and cyclic-AMP-regulated phosphoprotein, in the primate brain.
    Ouimet CC; LaMantia AS; Goldman-Rakic P; Rakic P; Greengard P
    J Comp Neurol; 1992 Sep; 323(2):209-18. PubMed ID: 1328330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlated light and electron microscopic study of dopaminergic neurons and their synaptic junctions with DARPP-32-containing cells in three-dimensional reaggregate tissue culture.
    Won L; Price S; Wainer BH; Hoffmann PC; Bolam JP; Greengard P; Heller A
    J Comp Neurol; 1989 Nov; 289(1):165-77. PubMed ID: 2572612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dopaminergic innervation of the pigeon telencephalon: distribution of DARPP-32 and co-occurrence with glutamate decarboxylase and tyrosine hydroxylase.
    Durstewitz D; Kröner S; Hemmings HC; Güntürkün O
    Neuroscience; 1998 Apr; 83(3):763-79. PubMed ID: 9483560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host dopaminergic afferents affect the development of DARPP-32 immunoreactivity in transplanted embryonic striatal neurons.
    Defontaines B; Peschanski M; Onteniente B
    Neuroscience; 1992 Jun; 48(4):857-69. PubMed ID: 1352865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-localization of the D1 dopamine receptor in a subset of DARPP-32-containing neurons in rat caudate-putamen.
    Langley KC; Bergson C; Greengard P; Ouimet CC
    Neuroscience; 1997 Jun; 78(4):977-83. PubMed ID: 9174066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical Localization of DARPP-32 in the Brain of Two Lungfishes: Further Assessment of Its Relationship with the Dopaminergic System.
    López JM; Morona R; González A
    Brain Behav Evol; 2017; 90(4):289-310. PubMed ID: 29161694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical localization of DARPP-32 in the brain of the lizard, Gekko gecko: co-occurrence with tyrosine hydroxylase.
    Smeets WJ; Lopez JM; González A
    J Comp Neurol; 2001 Jun; 435(2):194-210. PubMed ID: 11391641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DARPP-32 development in the caudate nucleus is independent of afferent input from the substantia nigra.
    Ehrlich ME; Rosen NL; Kurihara T; Shalaby IA; Greengard P
    Brain Res Dev Brain Res; 1990 Jul; 54(2):257-63. PubMed ID: 1975775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of intrastriatal striatal grafts and their afferent innervation from the host.
    Labandeira-Garcia JL; Wictorin K; Cunningham ET; Björklund A
    Neuroscience; 1991; 42(2):407-26. PubMed ID: 1716746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphometrical evidence for a complex organization of tyrosine hydroxylase-, enkephalin- and DARPP-32-like immunoreactive patches and their codistribution at three rostrocaudal levels in the rat neostriatum.
    Agnati LF; Fuxe K; Zoli M; Ferraguti F; Benfenati F; Ouimet CC; Walaas SI; Hemmings HC; Goldstein M; Greengard P
    Neuroscience; 1988 Dec; 27(3):785-97. PubMed ID: 2908056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. I. Regional and cellular distribution in the rat brain.
    Walaas SI; Greengard P
    J Neurosci; 1984 Jan; 4(1):84-98. PubMed ID: 6319627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ontogeny of phenylethanolamine N-methyltransferase- and tyrosine hydroxylase-like immunoreactivity in presumptive adrenaline neurones of the foetal rat central nervous system.
    Foster GA; Schultzberg M; Goldstein M; Hökfelt T
    J Comp Neurol; 1985 Jun; 236(3):348-81. PubMed ID: 2865276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ontogeny of the proenkephalin system in the rat corpus striatum: its relationship to dopaminergic innervation and transient compartmental expression.
    Song DD; Harlan RE
    Neuroscience; 1993 Feb; 52(4):883-909. PubMed ID: 8095712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of DARPP-32 immunoreactive structures in the quail brain: anatomical relationship with dopamine and aromatase.
    Absil P; Foidart A; Hemmings HC; Steinbusch HW; Ball GF; Balthazart J
    J Chem Neuroanat; 2001 Jan; 21(1):23-39. PubMed ID: 11173218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal dopamine lesion in the rat results in enhanced adenylate cyclase activity without altering dopamine receptor binding or dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein (DARPP-32) immunoreactivity.
    Luthman J; Lindqvist E; Young D; Cowburn R
    Exp Brain Res; 1990; 83(1):85-95. PubMed ID: 1981564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatial relationship of the striatonigral and mesostriatal pathways: double-label immunocytochemistry for DARPP-32 and tyrosine hydroxylase.
    Gustafson EL; Ouimet CC; Greengard P
    Brain Res; 1989 Jul; 491(2):297-306. PubMed ID: 2569911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.